Molecular requirements for epithelial-mesenchymal transition during tumor progression

被引:1522
作者
Huber, MA
Kraut, N
Beug, H
机构
[1] Vienna Med Univ, Dept Dermatol, A-1090 Vienna, Austria
[2] Inst Mol Pathol, A-1030 Vienna, Austria
[3] Boehringer Ingelheim Austria GmbH, Dept Lead Discovery, A-1121 Vienna, Austria
基金
奥地利科学基金会;
关键词
D O I
10.1016/j.ceb.2005.08.001
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Epithelial-mesenchymal transitions (EMTs) occur as key steps during embryonic morphogenesis, and are now implicated in the progression of primary tumors towards metastases. Recent advances have fostered a more detailed understanding of molecular mechanisms and networks governing EMT in tumor progression. Besides TGF beta and RTK/Ras signaling, autocrine factors and Wnt-, Notch-, Hedgehog- and NF-kappa B-dependent pathways were found to contribute to EMT. Repression of E-cadherin by transcriptional regulators such as Snail or Twist emerges as one critical step driving EMT, and this stage is currently being molecularly linked with many of the new players. Increasing evidence suggests that EMT plays a specific role in the migration of cells from a primary tumor into the circulation and may provide a rationale for developing more effective cancer therapies.
引用
收藏
页码:548 / 558
页数:11
相关论文
共 73 条
[1]   Glycogen synthase kinase-3 is an endogenous inhibitor of snail transcription: implications for the epithelial-mesenchymal transition [J].
Bachelder, RE ;
Yoon, SO ;
Franci, C ;
de Herreros, AG ;
Mercurio, AM .
JOURNAL OF CELL BIOLOGY, 2005, 168 (01) :29-33
[2]   Cancer and the chemokine network [J].
Balkwill, F .
NATURE REVIEWS CANCER, 2004, 4 (07) :540-550
[3]   Regulation of the cytoskeleton: An oncogenic function for CDK inhibitors? [J].
Besson, A ;
Assoian, RK ;
Roberts, JM .
NATURE REVIEWS CANCER, 2004, 4 (12) :948-955
[4]   Epithelial polarity and proliferation control:: links from the Drosophila neoplastic tumor suppressors [J].
Bilder, D .
GENES & DEVELOPMENT, 2004, 18 (16) :1909-1925
[5]   Cell adhesion and signalling by cadherins and Ig-CAMs in cancer [J].
Cavallaro, U ;
Christofori, G .
NATURE REVIEWS CANCER, 2004, 4 (02) :118-132
[6]   Dissemination and growth of cancer cells in metastatic sites [J].
Chambers, AF ;
Groom, AC ;
MacDonald, IC .
NATURE REVIEWS CANCER, 2002, 2 (08) :563-572
[7]   Intravital imaging of cell movement in tumours [J].
Condeelis, J ;
Segall, JE .
NATURE REVIEWS CANCER, 2003, 3 (12) :921-930
[8]   Hedgehog signalling in cancer formation and maintenance [J].
di Magliano, MP ;
Hebrok, M .
NATURE REVIEWS CANCER, 2003, 3 (12) :903-911
[9]   Targeting ras signalling pathways in cancer therapy [J].
Downward, J .
NATURE REVIEWS CANCER, 2003, 3 (01) :11-22
[10]   DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells [J].
Eger, A ;
Aigner, K ;
Sonderegger, S ;
Dampier, B ;
Oehler, S ;
Schreiber, M ;
Berx, G ;
Cano, A ;
Beug, H ;
Foisner, R .
ONCOGENE, 2005, 24 (14) :2375-2385